US Patent Issued to Merck Sharp & Dohme on Feb. 17 for "3-heteroaryl pyrrolidine and piperidine orexin receptor agonists" (New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,767, issued on Feb. 17, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"3-heteroaryl pyrrolidine and piperidine orexin receptor agonists" was invented by Stephane L. Bogen (Somerset, N.J.), Ping Chen (Edison, N.J.), Dane James Clausen (Rahway, N.J.), Xianhai Huang (Warren, N.J.), Michael T. Rudd (Collegeville, Pa.), Shawn P. Walsh (Bridgewater, N.J.), Lan Wei (Berkeley Heights, N.J.) and Dexi Yang (Livingston, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to 3-heteroaryl pyrrolidine and piperidine compounds which are agonists of orexin receptors. The present invention is also directed to uses of the c...